Abstract
Purpose
To investigate the threshold unenhanced CT density of adrenal nodules at which further evaluation with chemical shift MRI is unlikely to be definitive and therefore not helpful in further characterizing some indeterminate adrenal lesions.
Methods
Retrospective evaluation of 44 adrenal lesions imaged with unenhanced CT and chemical shift MRI and followed for at least 1 year. Qualitative and quantitative assessment of signal loss on chemical shift MRI was performed. Adenomas were diagnosed if the lesion measured equal or less than 10 HU on unenhanced CT; on MRI a SI index greater than 16.5% or adrenal:spleen chemical shift ratio less than 0.71 was considered diagnostic of adenoma.
Results
31.8% (14/44), 47.7% (21/44), and 20.5% (9/44) of the adrenal lesions had an unenhanced CT attenuation density ≤10, 10–30, and >30 HU. Adrenal lesions with an unenhanced CT density 10–30 and >30 HU had a 76.2% (16/21) and a 33.3% (3/9) chance of being categorized as an adenoma using MRI SI index, respectively.
Conclusions
Adrenal lesions with unenhanced attenuation CT density >30 HU had a 66.6% of remaining indeterminate even after evaluation with chemical shift MRI.
Advances in knowledge
Chemical shift MRI is reasonable for evaluating adrenal lesions with an unenhanced CT attenuation density less than 30 HU. The likelihood of chemical shift MRI detecting signal loss in lesions CT density greater than 30 HU, however, is low.
Similar content being viewed by others
References
Korobkin M, Francis IR, Kloos RT, Dunnick NR (1996) The incidental adrenal mass. Radiol Clin North Am 34(5):1037–1054
Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163–1168
Costa MAB, Carvalho TN, Araújo CR Jr, et al. (2005) Extrapulmonary manifestations of Manifestações extrapulmonares da paracoccidioidomycosis. Radiol Bras 38(1):45–52
Sinelnikov AO, Abujudeh HH, Chan D, Novelline RA (2007) CT manifestations of adrenal trauma: experience with 73 cases. Emerg Radiol 13(6):313–318
Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol 56(1):95–101
Boland GW, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171(1):201–204
Lee MJ, Hahn PF, Papanicolaou N, et al. (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179(2):415–418
Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM (1992) Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 185(2):345–351
Korobkin M, Brodeur FJ, Yutzy GG, et al. (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 166(3):531–536
Blake MA, Kalra MK, Sweeney AT, et al. (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238(2):578–585
Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175(5):1411–1415
Zeiger MA, Thompson GB, Duh QY, et al. (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1–20
Berland LL, Silverman SG, Gore RM, et al. (2010) Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7(10):754–773
Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231(3):711–716
Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA (2004) Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR Am J Roentgenol 183(1):215–219
Outwater EK, Siegelman ES, Huang AB, Birnbaum BA (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200(3):749–752
Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180(6):1649–1657
Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 202(5):1043–1050
Schindera ST, Soher BJ, Delong DM, Dale BM, Merkle EM (2008) Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience. Radiology 248(1):140–147
Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR (2006) CT histogram analysis in pathologically proven adrenal masses. AJR Am J Roentgenol 187(1):191–196
Jacques AE, Sahdev A, Sandrasagara M, et al. (2008) Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function. Eur Radiol 18(12):2885–2892
Caoili EM, Korobkin M, Francis IR, et al. (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222(3):629–633
Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266(2):514–520
Gupta RT, Ho LM, Marin D, et al. (2010) Dual-energy CT for characterization of adrenal nodules: initial experience. AJR Am J Roentgenol 194(6):1479–1483
Boland GW (2011) Adrenal imaging. Abdom Imaging 36(4):472–482
Bagheri B, Maurer AH, Cone L, Doss M, Adler L (2004) Characterization of the normal adrenal gland with 18F-FDG PET/CT. J Nucl Med 45(8):1340–1343
Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47(1):32–37
Sancho JJ, Triponez F, Montet X, Sitges-Serra A (2012) Surgical management of adrenal metastases. Langenbecks Arch Surg 397(2):179–194
Low G, Dhliwayo H, Lomas DJ (2012) Adrenal neoplasms. Clin Radiol 67(10):988–1000
Renard J, Clerici T, Licker M, Triponez F (2011) Pheochromocytoma and abdominal paraganglioma. J Visc Surg 148(6):e409–e416
Varghese JC, Hahn PF, Papanicolaou N, et al. (1997) MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times. Clin Radiol 52(8):603–606
Merkle EM, Schindera ST (2007) MR imaging of the adrenal glands: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15(3):365–372, vii
Savci G, Yazici Z, Sahin N, Akgoz S, Tuncel E (2006) Value of chemical shift subtraction MRI in characterization of adrenal masses. AJR Am J Roentgenol 186(1):130–135
Blake MA, Krishnamoorthy SK, Boland GW, et al. (2003) Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol 181(6):1663–1668
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sebro, R., Aslam, R., Muglia, V.F. et al. Low yield of chemical shift MRI for characterization of adrenal lesions with high attenuation density on unenhanced CT. Abdom Imaging 40, 318–326 (2015). https://doi.org/10.1007/s00261-014-0208-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0208-8